drug
ritlecitinib
Marketedupdated 3mo agoby $PFE PFIZER INC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying ritlecitinib
- —Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US
- phase2A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.
- phase2A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
- —A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings
- —Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
- phase2Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)
- —A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.
- phase3A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jun 23, 2028
~1.9 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (3)
- Oct 17, 2041compositionUS 12116368
- Dec 3, 2034method-of-use (U-3994)US 12077533
- Dec 3, 2034compositionUS 9617258
FDA exclusivities (1)
- Jun 23, 2028NCENew Chemical Entity (5y)1.9y
News(2)
- Sanofi to ‘rebuild trust’ with Regeneron; Apnimed adds to string of ‘upsized’ biotech IPOsSanofi wants to broaden the company’s productive partnership with Regeneron, its CEOs said. Elsewhere, Bristol Myers delayed two anticipated study readouts and a Shionogi-backed startup went public.biopharma_dive · 11d ago
- Pfizer's Phase 3 win for Litfulo; Braveheart, Attovia eye IPOs of $275M, $182MPfizer reports Phase 3 wins for Litfulo: The drug succeeded in two trials for active and stable nonsegmental vitiligo, an autoimmune condition that causes skin to progressively lose its color. One ...endpoints · 12d ago
Data sources
last refreshed 30m ago
Found something off?
comments(0)
5-min edit window · permanent after that